<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3"><gtr:id>5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3</gtr:id><gtr:name>Royal Netherlands Academy of Arts and Sciences (KNAW)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/64300AF7-F2A5-4EEC-983A-CC4168C9C664"><gtr:id>64300AF7-F2A5-4EEC-983A-CC4168C9C664</gtr:id><gtr:name>Virginia Commonwealth University</gtr:name><gtr:address><gtr:line1>Virginia Commonwealth University</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Molecular. Genetics &amp; Pop Health</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3"><gtr:id>5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3</gtr:id><gtr:name>Royal Netherlands Academy of Arts and Sciences (KNAW)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64300AF7-F2A5-4EEC-983A-CC4168C9C664"><gtr:id>64300AF7-F2A5-4EEC-983A-CC4168C9C664</gtr:id><gtr:name>Virginia Commonwealth University</gtr:name><gtr:address><gtr:line1>Virginia Commonwealth University</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5A0F238B-3522-4B97-BEC2-2E5429D05818"><gtr:id>5A0F238B-3522-4B97-BEC2-2E5429D05818</gtr:id><gtr:firstName>E.</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Patton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G120%2F875"><gtr:id>A65BEA53-8FA2-4961-98E1-5DD46D5911B3</gtr:id><gtr:title>Genetic Analysis of the Putative Oncogene INT6 in Zebrafish</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G120/875</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Significant insight into cancer development and treatment is found, in part, by studying cancer genes in model systems, such as the zebrafish. Many genes are highly conserved between zebrafish and humans, and mutations in zebrafish cancer genes can induce tumours that strongly resemble human cancers. Here, I propose to use the zebrafish system to rigorously probe the function of the putative cancer gene, INT6, in multi-drug resistance and cancer development.
INT6 is highly conserved with a clear role in cancer development, although the mechanisms behind this involvement remain mysterious. In fission yeast, Int6 maintains genome integrity, and regulates the multi-drug exposure response. In mice, integration of a virus into the INT6 gene results in truncated alleles of INT6 that appear to act in a dominant manner to promote breast cancer formation. Interestingly, in human cancers, loss of INT6 gene expression is frequently detected suggesting Int6 may also participate in suppressing tumour formation.
 For my first Aim, I will use gene knockdown and overexpression methods in zebrafish embryos to rapidly establish Int6 function in genome stability and multi-drug resistance. Genomic instability is a hallmark of cancer, and these studies will be greatly enhanced by collaborating with Dr. Charles Lee, Assistant Director, Harvard Cancer Center Cytogenetic Core.
 For my second Aim, I will create transgenic and mutant zebrafish lines that mimic Int6 mutations found in mammalian cancers, and yeast multi-drug resistance strains. In collaboration with Dr. Leonard Zon (Children?s Hospital Boston) I will identify Int6 loss-of-function alleles using a new method called TILLING that involves screening over 1500 F1 mutagenized fish for INT6 mutations. With an array of Int6 lines, I will ultimately determine the contribution of Int6 to tumourigenesis. As well, I will identify Int6 genetic interacting partners, focusing on those that reveal novel insights into Int6 mechanisms thatead to multi-drug resistance and increased rates of tumour development. Zebrafish tumour pathology will be in consultation with Dr. James Amatruda (Children?s Hospital), who has established a carcinogenesis assay in zebrafish. Finally, I will correlate Int6 tumour promoting mutations found in the zebrafish to those found in human cancers.
 These Aims will be the first to establish INT6 gene networks in vertebrates, as well as address the effects of multiple Int6 mutations in tumourigenesis. Many tumours acquire resistance to chemotherapy drugs, and pursuing the function of Int6 in multi-drug resistance has direct implications for a clinically important question in cancer treatment.</gtr:technicalSummary><gtr:fund><gtr:end>2008-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>467806</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of St Andrews</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry St Andrews</gtr:department><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>BBE848A8-A9DF-43C1-ADE8-CD586303DCEF</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-2</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Virginia Commonwealth University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Human and Molecular Genetics</gtr:department><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>9E762C1E-E181-4630-9B6B-1EC88671EAD4</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-5</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bath</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biology and Biochemistry</gtr:department><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>A139E1DD-26C4-4385-BED5-6286B0615035</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-3</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Netherlands Academy of Arts and Sciences (KNAW)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Hubrecht Institute</gtr:department><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>36C7CC29-14C6-4A03-982E-CCB13CCC4062</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-4</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Human genetic disease of the MAPK pathway</gtr:description><gtr:id>3EF75D93-2947-4A4E-91FD-29E5EE6E33C9</gtr:id><gtr:impact>Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors. Anastasaki C, Estep AL, Marais R, Rauen KA, Patton EE. Hum Mol Genet. 2009 Jul 15;18(14):2543-54. Epub 2009 Apr 17. PMID: 19376813 [PubMed - indexed for MEDLINE]


Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.
Rauen KA, Schoyer L, McCormick F, Lin AE, Allanson JE, Stevenson DA, Gripp KW, Neri G, Carey JC, Legius E, Tartaglia M, Schubbert S, Roberts AE, Gelb BD, Shannon K, Gutmann DH, McMahon M, Guerra C, Fagin JA, Yu B, Aoki Y, Neel BG, Balmain A, Drake RR, Nolan GP, Zenker M, Bollag G, Sebolt-Leopold J, Gibbs JB, Silva AJ, Patton EE, Viskochil DH, Kieran MW, Korf BR, Hagerman RJ, Packer RJ, Melese T.
Am J Med Genet A. 2010 Jan;152A(1):4-24.</gtr:impact><gtr:outcomeId>8609707C649-1</gtr:outcomeId><gtr:partnerContribution>Sharing of reagents, grant writing and publishing</gtr:partnerContribution><gtr:piContribution>Sharing of data, and ideas on human disease. We wrote a grant that was successfully funded, and have published in an medium impact journal.

We are currently exploring the effects of small molecules on behaviour.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>4000F08E-35CB-4B50-B71E-A9CE438B2F98</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-6</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Small molecule screening and melanoma models</gtr:description><gtr:id>7A46F75D-F216-42D1-96BE-5D81A412AE80</gtr:id><gtr:impact>We have successfully won funding from Medical Research Scotland, and have has a paper accepted in Disease Models and Mechanisms.
We have two other papers arising from this collaboration to be submitted within the next few months.</gtr:impact><gtr:outcomeId>B3C08899BC2-1</gtr:outcomeId><gtr:partnerContribution>Sharing of chemical reagents and successfully won Medical Research Scotland grant.We have had an excellent collaboration generating new small molecules and identifying how the compounds work in living animals and tissues. We will be submitting a paper together.We won a Medical Research Scotland Award, and have used this in a successful collaboration to carry out a small molecule screen. We will be submitting this to Pigment Cell and Melanoma Research for publication.We are on an FP7-EU grant together, and have developed new models of melanoma.We are developing new melanoma models together.We are sequencing zebrafish melanoma models.</gtr:partnerContribution><gtr:piContribution>We have been kindly given many small molecule tools which have been the basis for a successful grant for myself and a postdoc in the lab to Medical Research Scotland. We also had a paper accepted in Disease Models and Mechanisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Tour to cancer research fund raisers (lay people)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4621520B-700F-4902-BAB3-33315A68DAF2</gtr:id><gtr:impact>Two groups of 5 lay people who are interested in helping to raise money for cancer research. They toured the facility and we spent 1.5 hours with each group - showed melanoma models, discussed skin color and sun exposure. 

Tour of facilities and interaction day for children from a primary school in Fife.

The attendees were very grateful and sent a follow up e-mail to say how much they enjoyed it.</gtr:impact><gtr:outcomeId>opFot66f3nt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0AA74810-AD81-45A4-BBD8-9D55CB9176BC</gtr:id><gtr:impact>BBC interview on melanoma and cancer TV and radio

Interview with journalist from Scottish newspaper

Interview for the Scotsman

Surprised by how many people in my local community told me they had seen the interview on TV. Less impact with the radio interview.

Many people commented to me in the community that they had seen the Scotsman article</gtr:impact><gtr:outcomeId>66A3164A35B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2010,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2D6FE91A-FFE7-4218-B372-6E4481CE5A85</gtr:id><gtr:impact>Lecture at the Edinburgh science festival -- on cancer and zebrafish approaches to understanding disease and development, and why model organisms and basic science are so importnant

Many one-to-one discussions with audience members</gtr:impact><gtr:outcomeId>33BC8FD74D7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR funding (Gene-environment interactions in cancer)</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:id>468B8F36-F620-4B11-B51C-0DCD98098F98</gtr:id><gtr:outcomeId>E7D02AB1D3E0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 Framework</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>73E210CC-2D03-435E-A384-1465622C2C3C</gtr:id><gtr:outcomeId>5C3B107B75A0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>222258</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (A Critical Requirement for MAPK-signaling in Development and Disease)</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>13F67E4B-6F1C-4168-8619-0CFB7388801D</gtr:id><gtr:outcomeId>E9950A835240</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Scotland funding</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Scotland</gtr:fundingOrg><gtr:id>44B2BC3A-A8E7-46BC-A43B-D0DE1CC37532</gtr:id><gtr:outcomeId>98BDC7474320</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>a small molecule that causes a specific developmental phenotype (kills developing and differentiated melanocytes)</gtr:description><gtr:id>DCEC02F2-E40C-4FAD-9429-E12A73B15D75</gtr:id><gtr:impact>n/a considering for patent</gtr:impact><gtr:outcomeId>C747AA31E73</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Small molecule</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed an assay to test the activity of cardio-facio-cutaneous alleles, and to test the effects of specific clinically active drugs on restoring their &amp;quot;normal&amp;quot; activity</gtr:description><gtr:id>4F663825-DDCE-47E9-9CAE-A66073C41AA8</gtr:id><gtr:impact>Publication -- Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors. Anastasaki C, Estep AL, Marais R, Rauen KA, Patton EE. Hum Mol Genet. 2009 Jul 15;18(14):2543-54. Epub 2009 Apr 17. PMID: 19376813 [PubMed - indexed for MEDLINE]

Anastasaki C, Rauen KA, Patton EE. Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish. Dis Model Mech. 2012 Jul;5(4):546-52.</gtr:impact><gtr:outcomeId>31DAE82C6BA</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CFC-zebrafish</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19376813</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7ECAF731-D9D9-46B9-8081-98CFB2C52F1E</gtr:id><gtr:title>Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf3c200e2cedc5955838513cef90320c"><gtr:id>bf3c200e2cedc5955838513cef90320c</gtr:id><gtr:otherNames>Al-Olabi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5a9e77488965c9.25136466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1AC5693-D578-4020-8F40-135D83A86854</gtr:id><gtr:title>Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads.</gtr:title><gtr:parentPublicationTitle>Cell communication and signaling : CCS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94aaade2e9d35ffb15c39ffc30f2e535"><gtr:id>94aaade2e9d35ffb15c39ffc30f2e535</gtr:id><gtr:otherNames>Taylor KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1478-811X</gtr:issn><gtr:outcomeId>CudNRDYZ19q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D30F6C90-4C2F-4B13-BC60-9F55C9A1E1E7</gtr:id><gtr:title>The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ce84cab72cc356c1d67cb37a3ccc8f9"><gtr:id>1ce84cab72cc356c1d67cb37a3ccc8f9</gtr:id><gtr:otherNames>Yen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_15255_25_24148783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D95BB64E-8F05-4552-8673-B76A5F3264F7</gtr:id><gtr:title>Dopamine from the brain promotes spinal motor neuron generation during development and adult regeneration.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/933b6a4c26bb49ddb19fbe1a2676cc53"><gtr:id>933b6a4c26bb49ddb19fbe1a2676cc53</gtr:id><gtr:otherNames>Reimer MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>pm_15255_25_23707737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8D8C5FD-CD77-4712-90CE-F7477D06AA29</gtr:id><gtr:title>Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64df654b946ab3959a8d0b1c24653e0f"><gtr:id>64df654b946ab3959a8d0b1c24653e0f</gtr:id><gtr:otherNames>Anastasaki C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>C2EAED620DB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF7D5D3F-B617-4AC2-AF1A-4DEB2244037E</gtr:id><gtr:title>Generating and analyzing fish models of melanoma.</gtr:title><gtr:parentPublicationTitle>Methods in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0091-679X</gtr:issn><gtr:outcomeId>RGNYBBnE81u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B85CEA01-1585-4F58-897F-C6112B760D1C</gtr:id><gtr:title>Zebrafish have a competent p53-dependent nucleotide excision repair pathway to resolve ultraviolet B-induced DNA damage in the skin.</gtr:title><gtr:parentPublicationTitle>Zebrafish</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a111a9043650e30f5eae331d4f2c9b"><gtr:id>02a111a9043650e30f5eae331d4f2c9b</gtr:id><gtr:otherNames>Zeng Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1545-8547</gtr:issn><gtr:outcomeId>P7ELdhgWuZZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3CD9C74-9267-4AF7-82C7-DEEC135CF2C1</gtr:id><gtr:title>Combined zebrafish-yeast chemical-genetic screens reveal gene-copper-nutrition interactions that modulate melanocyte pigmentation.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ce8ef93758161a5b7ae3821c83ced0d"><gtr:id>6ce8ef93758161a5b7ae3821c83ced0d</gtr:id><gtr:otherNames>Ishizaki H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>cdhNHK2GaE3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2506A92B-F254-4955-8844-E0E73785E96A</gtr:id><gtr:title>Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64df654b946ab3959a8d0b1c24653e0f"><gtr:id>64df654b946ab3959a8d0b1c24653e0f</gtr:id><gtr:otherNames>Anastasaki C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_15255_25_22301711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFC4700C-24D3-4758-A196-F5B6DA7C40B5</gtr:id><gtr:title>Differentiated melanocyte cell division occurs in vivo and is promoted by mutations in Mitf.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94aaade2e9d35ffb15c39ffc30f2e535"><gtr:id>94aaade2e9d35ffb15c39ffc30f2e535</gtr:id><gtr:otherNames>Taylor KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>V8RSitnkW68</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BECFE501-FDBF-45C6-A93B-BA38E73E3EB3</gtr:id><gtr:title>Zebrafish Rpgr is required for normal retinal development and plays a role in dynein-based retrograde transport processes.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db00806632c3ff9c2dee3e5d6f9804c"><gtr:id>9db00806632c3ff9c2dee3e5d6f9804c</gtr:id><gtr:otherNames>Shu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>BFB6109A6AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F1485B3-FD3B-428D-AEA9-FEF351C680FB</gtr:id><gtr:title>Sharing chemical libraries within the European zebrafish community.</gtr:title><gtr:parentPublicationTitle>Zebrafish</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44d29c2750f7729ddffc3adb37267cca"><gtr:id>44d29c2750f7729ddffc3adb37267cca</gtr:id><gtr:otherNames>Grabher C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1545-8547</gtr:issn><gtr:outcomeId>RDTftXyZGwg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5694E98B-B801-4D02-909B-301F3FA63429</gtr:id><gtr:title>A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9adcead17be9031b569c1cdc871187a1"><gtr:id>9adcead17be9031b569c1cdc871187a1</gtr:id><gtr:otherNames>Lister JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15255_25_23831555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D35BB97E-2B89-41CC-B9AD-A7B53CC824B9</gtr:id><gtr:title>Knockdown of the zebrafish ortholog of the retinitis pigmentosa 2 (RP2) gene results in retinal degeneration.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db00806632c3ff9c2dee3e5d6f9804c"><gtr:id>9db00806632c3ff9c2dee3e5d6f9804c</gtr:id><gtr:otherNames>Shu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>mHS3aWaH6ZA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9019902-1107-4AB7-88C2-8EA4CD457AA7</gtr:id><gtr:title>Genetic models of cancer in zebrafish.</gtr:title><gtr:parentPublicationTitle>International review of cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d88d5a5e82037013765ad0dc4476bc0"><gtr:id>4d88d5a5e82037013765ad0dc4476bc0</gtr:id><gtr:otherNames>Amatruda JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1937-6448</gtr:issn><gtr:outcomeId>3DAA981F421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E1E19B0-2828-4757-B20D-5FCDBC596DF3</gtr:id><gtr:title>Small molecule screening identifies targetable zebrafish pigmentation pathways.</gtr:title><gtr:parentPublicationTitle>Pigment cell &amp; melanoma research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92954cdda9688e660ad9cecc318fa2d4"><gtr:id>92954cdda9688e660ad9cecc318fa2d4</gtr:id><gtr:otherNames>Colanesi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1755-1471</gtr:issn><gtr:outcomeId>pm_15255_25_22252091</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78AEEA27-FEC7-4FE8-8227-4BDBD70B8CFC</gtr:id><gtr:title>Rapid synthesis and zebrafish evaluation of a phenanthridine-based small molecule library.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99a8882f855d8758ccdbe32b185e6504"><gtr:id>99a8882f855d8758ccdbe32b185e6504</gtr:id><gtr:otherNames>Donaldson LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>qcGPT96bNYp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC53F2A4-1A34-4E11-83E4-4A2BE5FCABC5</gtr:id><gtr:title>A zebrafish model for nevus regeneration.</gtr:title><gtr:parentPublicationTitle>Pigment cell &amp; melanoma research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c851eb2d12d3a0bb01a4451e6b33fc0"><gtr:id>8c851eb2d12d3a0bb01a4451e6b33fc0</gtr:id><gtr:otherNames>Richardson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1755-1471</gtr:issn><gtr:outcomeId>SznVsjt9y3N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12C49E2D-1790-4A51-B958-04CF6137A868</gtr:id><gtr:title>DHX34 and NBAS form part of an autoregulatory NMD circuit that regulates endogenous RNA targets in human cells, zebrafish and Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fe57c499043fa731755dcdc48d96ebe"><gtr:id>3fe57c499043fa731755dcdc48d96ebe</gtr:id><gtr:otherNames>Longman D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_15255_25_23828042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7F0FD4B-3561-4548-A552-ACE6BF0D7B19</gtr:id><gtr:title>mc1r Pathway regulation of zebrafish melanosome dispersion.</gtr:title><gtr:parentPublicationTitle>Zebrafish</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c851eb2d12d3a0bb01a4451e6b33fc0"><gtr:id>8c851eb2d12d3a0bb01a4451e6b33fc0</gtr:id><gtr:otherNames>Richardson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1545-8547</gtr:issn><gtr:outcomeId>AEDD9654121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27E0759E-C383-4B9F-A870-AD3AE2DB1B15</gtr:id><gtr:title>A novel role for Glucocorticoid-Induced TNF Receptor Ligand (Gitrl) in early embryonic zebrafish development.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c41d2bf9a341063b77248da8e2ea40a"><gtr:id>7c41d2bf9a341063b77248da8e2ea40a</gtr:id><gtr:otherNames>Poulton LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>092847AA922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19FB1D0D-6464-4208-BD28-D97D4F10B20A</gtr:id><gtr:title>Live imaging in zebrafish reveals neu(trophil) insight into the metastatic niche.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>pm_15255_25_22611003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09285F25-D72B-4E1D-87DB-8E8F00489932</gtr:id><gtr:title>Dhx34 and Nbas function in the NMD pathway and are required for embryonic development in zebrafish.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64df654b946ab3959a8d0b1c24653e0f"><gtr:id>64df654b946ab3959a8d0b1c24653e0f</gtr:id><gtr:otherNames>Anastasaki C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>skQesppmr2d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E39129C-1473-4DE2-AB3D-C9A6EBE4D2EA</gtr:id><gtr:title>Genetic and environmental melanoma models in fish.</gtr:title><gtr:parentPublicationTitle>Pigment cell &amp; melanoma research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1755-1471</gtr:issn><gtr:outcomeId>HLmLcfUt4kJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D21DD477-3394-45CB-9C9B-B5FB5A650373</gtr:id><gtr:title>Topoisomerase II alpha is required for embryonic development and liver regeneration in zebrafish.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5cd49be9c05c60384c2408e85ff42bf"><gtr:id>b5cd49be9c05c60384c2408e85ff42bf</gtr:id><gtr:otherNames>Dovey M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>C13725CB8BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF374ED3-4BF1-4E37-BDA5-6534E19A2C98</gtr:id><gtr:title>Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f96aa26dd4824844aa3b47638e9597c"><gtr:id>7f96aa26dd4824844aa3b47638e9597c</gtr:id><gtr:otherNames>Rauen KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>YutKcBoukmv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C8F7145-199A-475E-9054-5C835620DE92</gtr:id><gtr:title>The INT6 cancer gene and MEK signaling pathways converge during zebrafish development.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b1356121a56c6fdc61a1549985596b4"><gtr:id>5b1356121a56c6fdc61a1549985596b4</gtr:id><gtr:otherNames>Grzmil M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>1EF9F4BD604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56EAF502-DD5F-4637-A7DF-18627EFBB1A6</gtr:id><gtr:title>Xmrk in medaka: a new genetic melanoma model.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>oyYbmLnwJ3p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E95474A4-9785-420E-AEAE-FC79755FBB29</gtr:id><gtr:title>Cancer: Trouble upstream.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c81331702bbc7905beb1fce2dd11641"><gtr:id>9c81331702bbc7905beb1fce2dd11641</gtr:id><gtr:otherNames>Patton EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15255_25_23518559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D42CDD9-8EE7-42F1-8C0F-96B152B82967</gtr:id><gtr:title>ALDH2 mediates 5-nitrofuran activity in multiple species.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/240a27c7bd5d10365eaae398f59768ee"><gtr:id>240a27c7bd5d10365eaae398f59768ee</gtr:id><gtr:otherNames>Zhou L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>pm_15255_25_22840776</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G120/875</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>